高田 慎也

Antiemetic Efficacy of Aprepitant in Cisplatin-Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study. 

Anticancer research 46(6) 3395-3406 2026年6月  

Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib. 

In vivo (Athens, Greece) 40(1) 532-537 2026年  

Impact of Abemaciclib-Induced Serum Creatinine Elevation on Dose Adjustment of Concomitant Medications. 

Oncology 1-8 2025年10月23日  

Prediction of Severe Anemia and Neutropenia Induced by Abemaciclib in Patients With Breast Cancer. 

Anticancer research 45(5) 2171-2183 2025年5月  

Pharmacist Intervention in Outpatients With Prostate Cancer Prevents Apalutamide-induced Skin Adverse Events. 

In vivo (Athens, Greece) 39(1) 459-466 2025年  

A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II). 

Scientific reports 14(1) 28271-28271 2024年11月16日  

Risk Factors for Eribulin-induced Severe Neutropenia in Patients With Recurrent Breast Cancer. 

In vivo (Athens, Greece) 38(1) 500-505 2024年  

Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatment. 

Scientific reports 13(1) 19457-19457 2023年11月9日  

Clinical Management of Potential Toxicity of Abemaciclib and Approaches to Ensure Treatment Continuation. 

Asian Pacific journal of cancer prevention : APJCP 24(6) 1955-1962 2023年6月1日  

Association between Area under the Curve Estimated from Carboplatin Dose and Incidence of Severe Thrombocytopenia in Patients with Non-Hodgkin's Lymphoma on DeVIC Therapy. 

Asian Pacific journal of cancer prevention : APJCP 24(6) 1963-1969 2023年6月1日  

Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study. 

Journal of Cancer 14(5) 676-688 2023年  

Real-World Predictors of Severe Neutropenia Associated with Palbociclib and Endocrine Therapy for Metastatic Breast Cancer in Japanese Patients. 

Biological & pharmaceutical bulletin 46(8) 1105-1111 2023年  

Serum Albumin Affects the Time-to-treatment Failure of Alectinib: A Multicenter Retrospective Study. 

In vivo (Athens, Greece) 37(5) 2260-2267 2023年  

Renin-angiotensin system inhibitors may have an advantage over calcium channel blockers in reducing proteinuria in gastric cancer patients receiving ramucirumab. 

Biomedical reports 17(3) 76-76 2022年9月  

Identifying Early Predictive Markers for Immune-Related Adverse Events in Nivolumab-Treated Patients with Renal Cell Carcinoma and Gastric Cancer. 

Asian Pacific journal of cancer prevention : APJCP 23(2) 695-701 2022年2月1日  

Analgesic effects of indomethacin spray on drug-induced oral mucositis pain in patients with cancer: A single-arm cross-sectional study. 

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 41(4) 498-504 2021年7月  

Predictors of the Onset of Type 1 Diabetes Obtained from Real-World Data Analysis in Cancer Patients Treated with Immune Checkpoint Inhibitors. 

Asian Pacific journal of cancer prevention : APJCP 21(6) 1697-1699 2020年6月1日  

Axitinib-Induced Hypothyroidism as a Predictor of Long-Term Survival in Patients with Metastatic Renal Cell Carcinoma. 

Urologia internationalis 102(4) 435-440 2019年